|
NLK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.41400002817704E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.63029999897557E-08 |
| Normal-vs-Stage2 |
2.222000E-03 |
| Normal-vs-Stage3 |
8.6710999491757E-09 |
| Normal-vs-Stage4 |
3.24551496788672E-12 |
| Stage1-vs-Stage2 |
2.996200E-01 |
| Stage1-vs-Stage3 |
2.195600E-01 |
| Stage1-vs-Stage4 |
6.785300E-04 |
| Stage2-vs-Stage3 |
6.504000E-02 |
| Stage2-vs-Stage4 |
9.249500E-04 |
| Stage3-vs-Stage4 |
6.267800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.65349989045671E-10 |
| Normal-vs-AfricanAmerican |
3.65079999999907E-05 |
| Normal-vs-Asian |
7.39140000316496E-08 |
| Caucasian-vs-AfricanAmerican |
8.873400E-01 |
| Caucasian-vs-Asian |
6.513000E-01 |
| AfricanAmerican-vs-Asian |
8.887800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.2275999996041E-07 |
| Normal-vs-Female |
1.21050003354384E-09 |
| Male-vs-Female |
7.097200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.61989999994494E-06 |
| Normal-vs-Age(41-60Yrs) |
7.65430052673821E-10 |
| Normal-vs-Age(61-80Yrs) |
2.58489999960254E-07 |
| Normal-vs-Age(81-100Yrs) |
1.527720E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.502000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.418400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.429000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.324200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.736600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.460800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.79656000000028E-05 |
| Classical-VS-Follicular |
4.758500E-04 |
| Classical-VS-Other |
8.306600E-01 |
| Classical-VS-Normal |
3.08969999585074E-08 |
| Tall-VS-Follicular |
4.9603999796588E-09 |
| Tall-VS-Other |
8.741200E-03 |
| Tall-VS-Normal |
1.15463194561016E-14 |
| Follicular-VS-Other |
3.846800E-01 |
| Follicular-VS-Normal |
2.593900E-02 |
| Other-VS-Normal |
1.916150E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.62049999991632E-07 |
| Normal-vs-N1 |
1.00899955057798E-10 |
| N0-vs-N1 |
3.756000E-03 |
|
|
